Business
Board Appointment
Board Appointment.
About this update from Futura Medical Plc
[{"type":"text","content":"\n\n31 March 2025\n \nFutura Medical plc\nBoard Appointment\nFutura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon®, that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, is pleased to announce the appointment of Harmesh Suniara to the Board as a Non-executive Director, with immediate effect\n \nHarmesh has over 17 years' experience of working in investment management, with a particular focus on UK small and mid-cap equities. Since 2017 he has worked as a Portfolio Manager at Lombard Odier Asset Management (Europe) Limited, and from 2007, he was an Investment Manager at Henderson Volantis Capital and Gartmore Investment Management.\n \nFunds or accounts managed on a discretionary basis by Lombard Odier Asset Management (Europe) Limited hold in aggregate 86,781,198 ordinary shares of Futura Medical, representing 28.56% of Futura Medical's issued share capital.\n \n \nJeff Needham, Chairman of Futura, commented:\n\"I am delighted to welcome Harmesh to the Board of Futura. We look forward to working with him as we continue our journey of meeting the unmet demand for sexual health products and take advantages of the opportunities available to us.\"\nThe following disclosures in relation to the appointment of Harmesh Kumar Suniara, aged 54, are required pursuant to Schedule 2(g) of the AIM Rules for Companies:\n \n\n\n\n\nCurrent\n\n\nPast 5 years\n\n\n\n\nC4X Discovery Holdings Limited\n\n\n\n\n\n\n\nIQE Plc\n\n\n\n\n\n\n\nActual Experience Plc\n\n\n\n\n\n\n\nHarmesh Suniara was a Director at Actual Experience Plc, which entered administration on 14 November 2023.\n \nNo further information is required to be disclosed pursuant to AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.\n \nContacts:\n\n\n\n\nFutura Medical plc\n \n \n \n\n\nJames Barder\nChief Executive Officer\nAngela Hildreth\nFinance Director and COO\n \n\n\[email protected]\n+44 (0)1483 685 670\nwww.futuramedical.com\n \n\n\n\n\nPanmure Liberum\nNominated Adviser\nand Broker\n \n\n\nEmma Earl, Will Goode, Mark Rogers (Corporate Finance)\nRupert Dearden (Corporate Broking)\n\n\n+44 (0)20 3100 2000\n \n \n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\nS...